A new trading day began on November 20, 2023, with Ginkgo Bioworks Holdings Inc (NYSE: DNA) stock priced at $1.51, up 0.66% from the previous day of trading. During the day, the shares moved up to $1.58 and dropped to $1.48 before settling in for the closing price of $1.52. DNA’s price has ranged from $1.12 to $2.55 over the past 52 weeks.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 180.81%. Meanwhile, its annual earnings per share averaged 66.70%. With a float of $1.30 billion, this company’s outstanding shares have now reached $1.34 billion.
The extent of productivity of a business whose workforce counts for 1292 workers is very important to gauge. In terms of profitability, gross margin is +44.35, operating margin of -452.56, and the pretax margin is -444.08.
Ginkgo Bioworks Holdings Inc (DNA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Ginkgo Bioworks Holdings Inc is 33.46%, while institutional ownership is 58.83%. The most recent insider transaction that took place on Nov 16, was worth 145,200. In this transaction an insider of this company sold 100,000 shares at a rate of $1.45, taking the stock ownership to the 5,094,680 shares. Before that another transaction happened on Nov 16, when Company’s 10% Owner sold 37,650 for $1.45, making the entire transaction worth $54,705. This insider now owns 12,562,794 shares in total.
Ginkgo Bioworks Holdings Inc (DNA) Latest Financial update
In its latest quarterly report, released on 9/29/2023, the company reported earnings of -$0.16 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a net margin of -440.63 while generating a return on equity of -129.87. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 66.70% per share during the next fiscal year.
Ginkgo Bioworks Holdings Inc (NYSE: DNA) Trading Performance Indicators
Here are Ginkgo Bioworks Holdings Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.45, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.28 in one year’s time.
Technical Analysis of Ginkgo Bioworks Holdings Inc (DNA)
The latest stats from [Ginkgo Bioworks Holdings Inc, DNA] show that its last 5-days average volume of 20.01 million was inferior to 20.85 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 69.98%. Additionally, its Average True Range was 0.13.
During the past 100 days, Ginkgo Bioworks Holdings Inc’s (DNA) raw stochastic average was set at 23.30%, which indicates a significant decrease from 64.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 120.13% in the past 14 days, which was higher than the 93.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6272, while its 200-day Moving Average is $1.6523. Now, the first resistance to watch is $1.5800. This is followed by the second major resistance level at $1.6300. The third major resistance level sits at $1.6800. If the price goes on to break the first support level at $1.4800, it is likely to go to the next support level at $1.4300. The third support level lies at $1.3800 if the price breaches the second support level.
Ginkgo Bioworks Holdings Inc (NYSE: DNA) Key Stats
With a market capitalization of 2.99 billion, the company has a total of 2,098,853K Shares Outstanding. Currently, annual sales are 477,710 K while annual income is -2,105 M. The company’s previous quarter sales were 55,430 K while its latest quarter income was -302,890 K.